Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) (”Aspire” or the “Company”), a developer of a multi-faceted patent-pending drug delivery technology, today provided an update on its two patent ...

Nonsteroidal anti-inflammatory drug use for over 2 years was associated with a lower risk for dementia, especially ...

Cancer remains one of the most devastating health challenges worldwide, with millions of people diagnosed every year.According to the World Health Organization, about one in five people develop cancer ...

Heart disease is the leading cause of death in the U.S., and for years doctors recommended older adults take a daily Aspirin.

With no differences between single or dual antiplatelet therapy or anticoagulants at 6 months, an RCT is warranted for ...

A team of researchers from the University of Cambridge believe they have uncovered the mechanism behind how aspirin, a common ...